Hellawell GO[Author] - Search Results

Year	Number of Results
1997	1
2000	1
2002	3
2003	1
2004	1
2005	4
2007	2
2008	1
2009	1
2011	1
2012	3
2018	1
2019	1
2024	0

1

Probiotics, dendritic cells and bladder cancer.

Feyisetan O, Tracey C, Hellawell GO. Feyisetan O, et al. Among authors: hellawell go. BJU Int. 2012 Jun;109(11):1594-7. doi: 10.1111/j.1464-410X.2011.10749.x. Epub 2011 Dec 16. BJU Int. 2012. PMID: 22176770 Review.

2

High dose rate prostate brachytherapy: an overview of the rationale, experience and emerging applications in the treatment of prostate cancer.

Challapalli A, Jones E, Harvey C, Hellawell GO, Mangar SA. Challapalli A, et al. Among authors: hellawell go. Br J Radiol. 2012 Nov;85 Spec No 1(Spec Iss 1):S18-27. doi: 10.1259/bjr/15403217. Br J Radiol. 2012. PMID: 23118099 Free PMC article. Review.

3

Ending the 'learning curve'.

Hellawell GO, Stolzenburg JU. Hellawell GO, et al. BJU Int. 2009 Jun;103(11):1454-5. doi: 10.1111/j.1464-410X.2009.08409.x. Epub 2009 Feb 11. BJU Int. 2009. PMID: 19220262 No abstract available.

4

Radiation exposure and the urologist: what are the risks?

Hellawell GO, Mutch SJ, Thevendran G, Wells E, Morgan RJ. Hellawell GO, et al. J Urol. 2005 Sep;174(3):948-52; discussion 952. doi: 10.1097/01.ju.0000170232.58930.8f. J Urol. 2005. PMID: 16094003

5

Performance Improvement (Pi) score: an algorithm to score Pi objectively during E-BLUS hands-on training sessions. A European Association of Urology, Section of Uro-Technology (ESUT) project.

Veneziano D, Canova A, Arnolds M, Beatty JD, Biyani CS, Dehò F, Fiori C, Hellawell GO, Langenhuijsen JF, Pini G, Rodriguez Faba O, Siena G, Skolarikos A, Tokas T, Van Cleynenbreugel BSEP, Wagner C, Tripepi G, Somani B, Lima B. Veneziano D, et al. Among authors: hellawell go. BJU Int. 2019 Apr;123(4):726-732. doi: 10.1111/bju.14621. Epub 2018 Dec 28. BJU Int. 2019. PMID: 30431700

6

Growth factors and their receptors in prostate cancer.

Hellawell GO, Brewster SF. Hellawell GO, et al. BJU Int. 2002 Feb;89(3):230-40. doi: 10.1046/j.1464-4096.2001.001067.x. BJU Int. 2002. PMID: 11856103 Review. No abstract available.

7

Laparoscopic radical prostatectomy: reducing the learning curve.

Hellawell GO, Moon DA. Hellawell GO, et al. Urology. 2008 Dec;72(6):1347-50. doi: 10.1016/j.urology.2007.12.027. Epub 2008 Apr 8. Urology. 2008. PMID: 18400266

8

What are the risks of second cancer formation after radiotherapy to the prostate?

Hellawell GO, Dearden JC. Hellawell GO, et al. BJU Int. 2007 Mar;99(3):698. doi: 10.1111/j.1464-410X.2007.06779_1.x. BJU Int. 2007. PMID: 17407526 No abstract available.

9

Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer.

Rochester MA, Riedemann J, Hellawell GO, Brewster SF, Macaulay VM. Rochester MA, et al. Among authors: hellawell go. Cancer Gene Ther. 2005 Jan;12(1):90-100. doi: 10.1038/sj.cgt.7700775. Cancer Gene Ther. 2005. PMID: 15499378

10

Does cooling Sengstaken-Blakemore tubes aid insertion? An evidence based approach.

Dearden JC, Hellawell GO, Pilling J, Besherdas K, Van Someren N. Dearden JC, et al. Among authors: hellawell go. Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1229-32. doi: 10.1097/00042737-200411000-00023. Eur J Gastroenterol Hepatol. 2004. PMID: 15489586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

19 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year